FDA Approves Everolimus to Prevent Organ Rejection in Renal Transplant Recipients - DG News PDF Print
DG NewsNEW YORK -- April 22, 2010 -- The US Food and Drug Administration (FDA) has approved everolimus (Zortress) oral tablets for the prevention of organ ...Everolimus Okayed for Preventing Renal Transplant Rejection Renal and Urology NewsFDA Clears Novartis' Zortress for Preventing Organ Rejection in Kidney

... read more

 
Share |
Copyright © 2026 Global Dialysis. All Rights Reserved.